Eli Lilly’s $3.5 Billion Pennsylvania Plant Marks High-Stakes Test for U.S. Pharma Manufacturing February 5, 2026
Federal Judge Clears Path for Class Action Targeting Nordic Ware’s “Made in USA” Labels January 8, 2026
Data Study: The Impact So Far of the De Minimis Rule Suspension in the United States January 28, 2026